Smoking and oxidative stress markers useful for improving anxiety and depression disease outcomes

L. Trofor (Cagnes sur Mer, France), I. Buculei (Iasi, Romania), I. Grosu-Creanga (Iasi, Romania), M. Cioroiu (Iasi, Romania), A. Trofor (Iasi, Romania)

Source: Virtual Congress 2020 – Smoking disease landscape: from inflammation to lung function and comorbidities
Session: Smoking disease landscape: from inflammation to lung function and comorbidities
Session type: E-poster session
Number: 1324
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Trofor (Cagnes sur Mer, France), I. Buculei (Iasi, Romania), I. Grosu-Creanga (Iasi, Romania), M. Cioroiu (Iasi, Romania), A. Trofor (Iasi, Romania). Smoking and oxidative stress markers useful for improving anxiety and depression disease outcomes. 1324

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Oxidative stress, antioxidant and clinical symptoms in childhood asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 482s
Year: 2006

The impact of anxiety and depression on outcomes of pulmonary rehabilitation in COPD
Source: Annual Congress 2011 - What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life
Year: 2011

Early life psychosocial stressors increase asthma severity in later childhood
Source: Eur Respir J 2005; 26: Suppl. 49, 43s
Year: 2005

Smoking status and levels of anxiety and depression in hospitalized patients.
Source: International Congress 2018 – Effect of tobacco use on health
Year: 2018

An evaluation of the effects of cognitive behavioural therapy on quality of life and anxiety and depression in COPD patients undergoing pulmonary rehabilitation
Source: Eur Respir J 2007; 30: Suppl. 51, 95s
Year: 2007

Effect of pulmonary rehabilitation on health status, depression and anxiety
Source: Annual Congress 2006 - Outcomes in pulmonary rehabilitation
Year: 2006


The impact of asthma on quality of life, anxiety and depression scores
Source: International Congress 2017 – Bronchial asthma management
Year: 2017

Study of biochemical markers of oxidative stress in smokers versus nonsmokers with mixed anxious and depressive disorder
Source: International Congress 2019 – Challenges in tobacco control and cessation
Year: 2019

Emotional distress in children with problematic severe asthma is associated with parental anxiety and depression
Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations
Year: 2018

Does depression disorder have an important impact in smoking cessation?
Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations
Year: 2018

Management of depression and anxiety in COPD
Source: Eur Respir Mon 2013; 59: 144-163
Year: 2013


Assessment of quality of life, anxiety and depression in patients with chronic cough
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007


COPD: clinical, personality characteristics and psychological defences in development of disadaptive types of attitude to illness
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018


Smoking, anxiety and depression in relation to chronic respiratory diseases: results of population survey ROSEPID
Source: Annual Congress 2009 - Tobacco, bronchial tubes and the lung
Year: 2009


Do anxiety and depression affect patients‘ perceived level of asthma control?
Source: Annual Congress 2008 - Markers and triggers of asthma
Year: 2008

The influence of anxiety and depression on health care use and quality of life in asthma patients
Source: Eur Respir J 2004; 24: Suppl. 48, 519s
Year: 2004

Elevated systemic biomarkers and persistent anxiety and depression in smokers with and without COPD: An analysis of the SPIROMICS cohort
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017


Immersive virtual reality as a method supporting pulmonary rehabilitation: Evaluation of the intensity of depressive and anxiety symptoms and stress levels
Source: Virtual Congress 2021 – Symptoms across respiratory diseases and impact of COVID-19
Year: 2021


Psychological factors
Source: Eur Respir Mon 2012; 56: 143-157
Year: 2012


Effects of personality disorders and asthma severity on life quality
Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2010